Hello and welcome to Business Daily from the BBC with me, Manuel Zaragoza. Coming up, what would a vaccine

against malaria do for economies where the killer disease is rife? The ultimate goal, of course,

is not to control malaria. It's to eliminate it. Once you've done that, then you've saved 400,000

lives plus 200 million cases of illness.

We speak to the man who led the team behind a new malaria vaccine, which many say will be a game changer.

But given it took only a year to develop a COVID vaccine, why has finding one for malaria taken so long?

The pharmaceutical companies are much more interested, of course,

in making products for populations that can afford to pay a high price

than for poor people in developing countries.

That's all here in Business Daily from the BBC.

Oh, it was when you're really ill with malaria, then you feel very bad.

You know, I was so tired. I couldn't do anything.

I was actually vomiting that time.

And everybody around you is panicking because they don't know whether you're going to survive.

Our mothers are panicking, fathers are panicking.

Professor Obina-on-Wiqe in Nigeria, remembering the time he was hospitalized with malaria when he was nine years old.

It wasn't the only time he caught the disease.

Malaria infected well over 200 million people last year and killed almost half a million, most of them children.

But in Nigeria, people have come to accept malaria as part of life.

Most people get it at least once or twice a year. So everybody has resigned themselves to

faith. That malaria is here and there's nothing we can do about it. We just try to limit a number of times we can have it by taking preventive measures,

like try to stay indoors, wear it socks. Every house now has a mosquito net.

...